Epidemiological update: Measles - monitoring European outbreaks, 4 August 2017
Romania and Italy have been experiencing large outbreaks of measles in 2017. Cases continue to be reported despite ongoing response measures (reinforced vaccination activities) at the national level. All EU/EEA countries have reported measles cases this year, except for Latvia, Liechtenstein, Malta and Norway.
Update of the week
Updates were received from the following EU/EEA countries (see also below): Belgium, the Czech Republic, Finland, Germany, Italy, Romania and the United Kingdom. Several other countries have also reported outbreaks. According to national public health authorities, measles have caused 40 deaths in several EU countries in 2016 and 2017 due to current outbreaks. In 2016, deaths occurred in Romania (12) and the UK (1). In 2017, deaths were reported from Romania (20), Italy (3), Bulgaria (1), Germany (1), Portugal (1) and France (1).
EU/EEA countries with updates since last week:
Belgium: From late June until 26 July 2017: outbreak in a Ghent prison with 19 cases (14 prisoners and five staff members).
Czech Republic: Three additional cases since the report on 23 June 2017. Since the beginning of 2017 and as of 30 July, the Czech Republic reported 133 measles cases. During the same time period in 2016, the Czech Republic reported four cases.
Finland: On 3 August 2017, Finland reported a cluster of four measles cases among Finnish travellers returning from Italy. All cases had been vaccinated twice against measles and had mild rash and fever symptoms. Since the beginning of the year and as of 3 August 2017, and adding the cluster above, eight cases of measles have been reported in Finland, compared with one for the same time period in 2016.
Germany: An increase of 13 cases since the last report on 28 July 2017 was reported. Since the beginning of 2017 and as of 2 August, Germany reported 814 measles cases. During the same time period in 2016, Germany reported 196 cases.
Italy: An increase of 159 cases since the last report on 28 July 2017 was reported. Since the beginning of 2017 and as of 1 August, Italy reported 4 001 cases, including three deaths. Among the cases, 275 are healthcare workers. The median age is 27 years, 89% of the cases were not vaccinated, and 6% received only one dose of vaccine. During the same time period in 2016, Italy reported 522 cases.
Romania: An increase of 101 cases since the last report on 28 July 2017 was reported. Since 1 January 2016 and as of 28 July 2017, Romania reported 8 347 cases, including 32 deaths. Of these, 1 969 cases were reported during 2016, and 6 378 cases were reported between January 2017 and 28 July.
United Kingdom: Public Health Wales reported two additional cases related to the outbreak in Newport and Torfaen, bringing the number of cases related to this outbreak to 12. Since the last report on 28 July 2017, England and Wales report an increase by 40 cases. Since the beginning of 2017 and as of 30 July 2017, England and Wales report 962 cases. In the same time period in 2016, they reported 996 cases.
Measles outbreaks continue to occur in EU/EEA countries. There is a risk of spread and sustained transmission in areas with susceptible populations. Vaccination with two doses remains the most effective measure.
All EU/EEA countries report measles cases on a monthly basis to ECDC, and these data are published every month. Since 10 March 2017, ECDC has been reporting on measles outbreaks in Europe on a weekly basis. ECDC also monitors worldwide outbreaks on a monthly basis through epidemic intelligence activities. ECDC published a rapid risk assessment on 6 March 2017
Read more on this site
Rapid risk assessment: ongoing outbreak of measles in Romania, risk of spread and epidemiological situation in EU/EEA countries, 3 March 2017
This rapid risk assessment reviews the ongoing outbreak of measles in Romania as well as the risk of spread and epidemiological situation of measles in EU/EEA countries.
Communicable disease threats report, 30 July - 5 August, week 31
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July – 5 August 2017 and includes updates on hepatitis A, West Nile virus, Vibrio, measles, seasonal influenza, MERS, and Legionnaires' disease.
Monthly measles and rubella monitoring reports
ECDC publishes a monthly surveillance report on measles and rubella data submitted by the 30 EU/EEA countries.Read more
Measles affects all age groups
Measles can be contracted at any age. Infants and children are often believed to be the only age groups affected by measles, but the disease also spreads among teenagers and adults, so check your vaccination status.Read more
Immunisation is a safe and cost-effective way to protect people – especially infants and young children – from certain infectious diseases. All EU countries have a 'vaccination schedule', recommending the vaccines to be given at various ages during childhood. However, too many children in Europe go unvaccinated and remain vulnerable to potentially life-threatening diseases.Read more
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.Read more
European Immunization Week, 2018
23 Apr 2018 to 29 Apr 2018 - European Immunization Week (EIW) is marked across the European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. Activities in 2018 focused on the progress and challenges in the Region’s concerted effort to eliminate measles and rubella.
Immunisation and vaccines
Vaccines represent one of the most effective and cost-saving public health intervention.Read more
Measles is an acute, highly contagious viral disease capable of causing epidemics. Infectivity is close to 100% in susceptible individuals and in the pre-vaccine era measles would affect nearly every individual during childhood.Read more